Post job

BioScrip main competitors are eviCore healthcare, Sheridan Healthcorp Inc, and HomeChoice Partners.

Competitor Summary. See how BioScrip compares to its main competitors:

  • EviCore healthcare has the most employees (7,500).
  • Employees at eviCore healthcare earn more than most of the competitors, with an average yearly salary of $59,988.
Work at BioScrip?
Share your experience

BioScrip vs competitors

CompanyFounding dateZippia scoreHeadquarters# of LocationsRevenueEmployees
1993
4.6
Denver, CO8$900.6M2,072
1996
4.6
Somers Point, NJ1$50.0M500
1988
4.4
Brecksville, OH1$48.0M375
Intravenous Therapy Services
-
3.6
Burbank, CA1$590,0003
1988
4.7
Denver, CO71$1.2B4,600
2008
4.5
Denver, CO1$27.0M50
1994
4.6
Bluffton, SC6$470.6M7,500
2010
4.1
New York, NY1$5.0M7,500
1968
4.6
White Plains, NY17$73.0M529
1996
4.5
Hartford, CT2$48.7M1,555
1995
4.7
Malvern, PA12$439.1M1,500
2006
4.3
Greenwood Village, CO1$28.4M200
-
4.7
Sunrise, FL1$150.0M1,195
-
4.0
Arlington Heights, IL1$5.4M300
2003
4.6
Blue Bell, PA5$105.3M1,001
1993
4.3
Somerville, MA1$7.1M135
1996
4.6
Phoenix, AZ1$1.4B1,700
1996
3.6
Norfolk, VA1$14.0M750
1989
4.4
Katy, TX1$8.2M78
1977
3.5
Anchorage, AK1$1.8M35
1992
4.2
Montgomery, AL1$20.0M148

Rate how well BioScrip differentiates itself from its competitors.

Zippia waving zebra

BioScrip salaries vs competitors

Among BioScrip competitors, employees at eviCore healthcare earn the most with an average yearly salary of $59,988.

Compare BioScrip salaries vs competitors

CompanyAverage salaryHourly salarySalary score
BioScrip
$45,990$22.11-
Home Infusion Solutions
$45,809$22.02-
Clinical Specialties
$40,182$19.32-
Coram
$43,113$20.73-
Coram Healthcare Corporation of Southern Florida
$49,920$24.00-
eviCore healthcare
$59,988$28.84-

Compare BioScrip job title salaries vs competitors

CompanyHighest salaryHourly salary
BioScrip
$68,202$32.79
Coram
$78,844$37.91
TriWest Healthcare Alliance
$73,711$35.44
Turenne PharMedCo
$71,931$34.58
Hotze Health
$71,373$34.31
Amerita
$71,066$34.17
Coram Healthcare Corporation of Southern Florida
$70,131$33.72
CareCentrix
$69,833$33.57
Home Infusion Solutions
$69,690$33.50
Intravenous Therapy Services
$69,591$33.46
HomeChoice Partners
$69,554$33.44
Geneva Woods Pharmacy
$69,333$33.33
BioTelemetry
$68,956$33.15
Byram Healthcare
$68,707$33.03
Senior Vna Living Comm
$68,541$32.95
eviCore healthcare
$67,975$32.68
Preferred Home Care of NY
$67,941$32.66
Clinical Specialties
$67,865$32.63
UBC
$67,007$32.21
American Health Center
$62,247$29.93

Do you work at BioScrip?

Is BioScrip able to compete effectively with similar companies?

BioScrip jobs

BioScrip demographics vs competitors

Compare gender at BioScrip vs competitors

Job titleMaleFemale
eviCore healthcare24%76%
TriWest Healthcare Alliance24%76%
BioScrip30%70%
Byram Healthcare32%68%
Sheridan Healthcorp Inc33%67%
BioTelemetry47%53%

Compare race at BioScrip vs competitors

CompanyWhiteHispanic or LatinoBlack or African AmericanAsianUnknownDiversity score
65%13%11%7%4%
9.8
62%15%10%10%4%
9.6
60%21%9%6%3%
8.2
59%14%16%7%3%
9.8
58%18%13%9%3%
9.9
61%20%7%7%5%
9.7

BioScrip and similar companies CEOs

CEOBio
Joseph H. Capper
BioTelemetry

Joseph H. Capper was appointed President and Chief Executive Officer of CardioNet in June 2010. Prior to CardioNet, Joe served as President, Chief Executive Officer and member of the Board of Directors of Home Diagnostics, Inc., a leading developer, manufacturer and marketer of diabetes management products. Joe joined Home Diagnostics in 2009 and positioned the Company for a strategic merger in a transaction that created substantial value to its stakeholders. Home Diagnostics was listed on the NASDAQ stock market until its strategic merger. Prior to Home Diagnostics, Joe was President and Chief Executive Officer of CCS Medical Inc., a private company that is a leading provider of medical supplies in diabetes, wound care, respiratory and other therapeutic categories. During Joe's tenure as Chief Executive Officer, he built the Company into one of the largest providers of diabetes and respiratory testing supplies for Medicare beneficiaries and the private insured. During this time, the Company's revenue grew from $60 million to over $500 million through organic growth and acquisitions.

Perry Bernocchi
Byram Healthcare

Perry Bernocchi is a CEO at Byram Healthcare and is based in White Plains, New York. He has worked as Sr VP Operations at Coram CVS/specialty infusion services, Sr. VP Operations/COO at Hemophilia Resources of America, and EVP Operations at Byram Healthcare. Perry attended Rider University between 1976 and 1980.

John Arlotta
eviCore healthcare

Mr. Luis E. Dini
Home Infusion Solutions

Mr. Luis E. Dini is a Chairman - Chief Executive Officer at Home Solutions and is based in United States.

John Carlyle is a Founder at Magella Healthcare, Chief Executive Officer at Sheridan Healthcare, and Operating Partner at Riata Capital Group. He has worked as Chairman at Pediatrix Medical Group Inc, Chief Financial Officer at Medical Care Intl Inc, and Board Member at Eagle Hospital Physicians. John studied at University of Texas at Arlington.

David McIntyre works at TriWest Healthcare Alliance and a President/CEO at TriWest Healthcare Alliance. He has worked as Chief Architect at TriWest Healthcare Alliance and President at Blue Cross & Blue Shield Assn. David works or has worked as BOARD MEMBER at Congressional Medal of Honor Foundation and TRUSTEE at Congressional Medal of Honor Foundation. He studied at Johns Hopkins University and Seattle Pacific University.

Bill Turenne
Turenne PharMedCo

Patrick Lindsay
UBC

John Driscoll
CareCentrix

John Driscoll brings more than 25 years of health care experience to CareCentrix. Prior to CareCentrix, John served as President at Castlight Health, a healthcare technology company. Previously, John served as Group President for new markets at Medco (a $70 billion Pharmacy Benefit Manager). He led product development for employer and health plan clients. During his years at Medco, John was part of the senior management team that spun Medco out of Merck, building an enterprise that was named as the most admired company in healthcare services by Fortune. He was responsible for Medco’s entry into Medicare, growing the business from start-up to $20 billion in annual revenue. John also led Medco’s acquisitions and investments, investing over $10 billion in capital in high-growth companies, including specialty pharmacy Accredo Health. During John’s tenure, he was also in charge of Retail network contracting, Medco’s data products, Medco International, and Medco’s specialty pharmacy business. John founded and chaired the Surescripts ePrescribing Network, building the first cross-industry collaborative with competing Retail, PBM, and Health Plans cooperating to revolutionize e-prescribing. Surescripts has grown from servicing under 50 million prescriptions in 2005, to over 1 billion prescriptions today. John also served as an Advisor to Oak Investment Partners. He was a member of the executive team at Oxford Health Plans, serving as Corporate Vice President for government programs. At Oxford Health Plans, he built and led the Medicare & Medicaid business, from start-up to over $1.3 billion in annual revenue. During his time at Oxford, the company was one of the fastest growing companies in the U.S. and was widely recognized as one of the most innovative companies in healthcare. John was selected by the White House for its Entrepreneurs in Residence program in 2011 to advise the FDA on new paths for innovation. He has published articles in Los Angeles Times and Time Magazine. John has a B.A. and M.B.A. from Harvard University, and was a resident tutor at Winthrop House. John also holds an MPhil from Cambridge University in England. He chairs the Truman National Security Project, and served as a captain in the U.S. Army Reserve. He serves as a Board Member for the Alliance for Hunger and the Press Ganey Corporation, and previously served on the Board of Outward Bound, Hurricane Island Outward Bound School, and the Domus Foundation.

BioScrip competitors FAQs

Search for jobs